Pustular psoriasis triggered by therapy with atezolizumab and bevacizumab

An Bras Dermatol. 2024 Jan-Feb;99(1):153-155. doi: 10.1016/j.abd.2023.02.003. Epub 2023 Aug 30.

Authors

Mariani Magnus da Luz Andrade¹, Guilherme Ladwig Tejada², Juliano Peruzzo², Renan Rangel Bonamigo²

Affiliations

¹ Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: mmdandrade@hcpa.edu.br.
² Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab / adverse effects
Humans
Liver Neoplasms*
Psoriasis* / drug therapy

Substances

Bevacizumab
atezolizumab
Antibodies, Monoclonal, Humanized